Literature DB >> 15964681

Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS.

Guillermo M Alexander1, M A van Rijn, J J van Hilten, Marielle J Perreault, Robert J Schwartzman.   

Abstract

Complex Regional Pain Syndrome (CRPS) Types I and II are characterized by various combinations of sensory, autonomic and motor abnormalities. Pain disproportionate to the severity and duration of the inciting event is the most devastating symptom. In animal studies, conditions resulting in exaggerated pain states demonstrate elevated pro-inflammatory cytokines. In addition, pro-inflammatory cytokines have been shown to induce or increase neuropathic and inflammatory pain. Utilizing high sensitivity enzyme linked immunosorbent assay (ELISA), we compared the levels of the pro-inflammatory cytokines interleukin-1beta (IL-1beta), interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha) in the cerebrospinal fluid (CSF) of patients afflicted with CRPS to CSF levels found in other patients with and without painful conditions. The results from this study demonstrated significant increases in IL-1beta and IL-6, but not TNF-alpha in the CSF of individuals afflicted with CRPS as compared to controls. CSF cytokine levels in controls with painful conditions did not differ from levels in controls without pain. These increases showed no correlation with the patient's gender or weight. These results are consistent with studies that suggest that the pathogenesis of CRPS is due in part to central neuroimmune activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964681     DOI: 10.1016/j.pain.2005.04.013

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  82 in total

Review 1.  Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review.

Authors:  Pari Azari; David R Lindsay; Dean Briones; Collin Clarke; Thomas Buchheit; Srinivas Pyati
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

2.  Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model.

Authors:  Karin N Westlund; Liping Zhang; Fei Ma; Helieh S Oz
Journal:  Transl Res       Date:  2011-11-08       Impact factor: 7.012

3.  Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain.

Authors:  A Vania Apkarian; Simona Lavarello; Anke Randolf; Hector H Berra; Dante R Chialvo; Hugo O Besedovsky; Adriana del Rey
Journal:  Neurosci Lett       Date:  2006-09-14       Impact factor: 3.046

4.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

Review 5.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

Review 6.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 7.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

8.  Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.

Authors:  W-W Li; T-Z Guo; X Shi; Y Sun; T Wei; D J Clark; W S Kingery
Journal:  Neuroscience       Date:  2015-09-16       Impact factor: 3.590

Review 9.  Neuropathic Pain: Central vs. Peripheral Mechanisms.

Authors:  Kathleen Meacham; Andrew Shepherd; Durga P Mohapatra; Simon Haroutounian
Journal:  Curr Pain Headache Rep       Date:  2017-06

10.  Gardner-Diamond syndrome associated with complex regional pain syndrome.

Authors:  Lara K Edinger; Robert J Schwartzman
Journal:  J Dermatol Case Rep       Date:  2013-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.